Concepts (233)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Incontinence, Stress | 12 | 2013 | 31 | 1.360 |
Why?
|
| BCG Vaccine | 3 | 2021 | 108 | 0.880 |
Why?
|
| Immunization, Secondary | 1 | 2021 | 105 | 0.710 |
Why?
|
| Contraception, Postcoital | 2 | 2010 | 3 | 0.690 |
Why?
|
| Norpregnadienes | 2 | 2010 | 7 | 0.690 |
Why?
|
| Mortality | 1 | 2021 | 243 | 0.650 |
Why?
|
| Pelvic Floor | 4 | 2007 | 33 | 0.590 |
Why?
|
| Tuberculosis | 7 | 2021 | 531 | 0.590 |
Why?
|
| Leprosy | 6 | 2021 | 19 | 0.570 |
Why?
|
| Disease Transmission, Infectious | 3 | 2013 | 84 | 0.560 |
Why?
|
| Urinary Incontinence | 7 | 2024 | 71 | 0.560 |
Why?
|
| Vaccination | 3 | 2021 | 970 | 0.530 |
Why?
|
| Malawi | 14 | 2021 | 399 | 0.500 |
Why?
|
| Exercise Therapy | 2 | 2007 | 162 | 0.490 |
Why?
|
| Uterine Prolapse | 6 | 2008 | 18 | 0.430 |
Why?
|
| Cholera | 1 | 2013 | 25 | 0.410 |
Why?
|
| Family Characteristics | 1 | 2013 | 80 | 0.390 |
Why?
|
| Longitudinal Studies | 4 | 2013 | 1341 | 0.390 |
Why?
|
| Anesthesiology | 1 | 2013 | 95 | 0.370 |
Why?
|
| Gynecologic Surgical Procedures | 5 | 2014 | 60 | 0.370 |
Why?
|
| Pregnancy, Unwanted | 1 | 2010 | 4 | 0.360 |
Why?
|
| Puerperal Disorders | 2 | 2007 | 45 | 0.340 |
Why?
|
| Anesthesia | 1 | 2013 | 206 | 0.340 |
Why?
|
| Contraceptives, Postcoital, Hormonal | 1 | 2010 | 1 | 0.340 |
Why?
|
| Postpartum Period | 3 | 2007 | 216 | 0.320 |
Why?
|
| Fecal Incontinence | 5 | 2024 | 72 | 0.310 |
Why?
|
| Mycobacterium leprae | 2 | 2021 | 4 | 0.300 |
Why?
|
| Voluntary Health Agencies | 1 | 2007 | 5 | 0.290 |
Why?
|
| Condylomata Acuminata | 1 | 2007 | 15 | 0.290 |
Why?
|
| Pelvic Floor Disorders | 2 | 2024 | 9 | 0.260 |
Why?
|
| Adult | 30 | 2021 | 29800 | 0.260 |
Why?
|
| Female | 45 | 2024 | 67337 | 0.260 |
Why?
|
| Counseling | 1 | 2007 | 223 | 0.240 |
Why?
|
| Middle Aged | 27 | 2021 | 27046 | 0.230 |
Why?
|
| Health Care Costs | 1 | 2007 | 377 | 0.230 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2001 | 383 | 0.220 |
Why?
|
| Follow-Up Studies | 8 | 2021 | 5202 | 0.220 |
Why?
|
| Tuberculin Test | 2 | 2006 | 123 | 0.210 |
Why?
|
| Pelvic Organ Prolapse | 2 | 2014 | 25 | 0.210 |
Why?
|
| Treatment Outcome | 14 | 2021 | 12386 | 0.210 |
Why?
|
| Fasciitis, Necrotizing | 1 | 2003 | 28 | 0.210 |
Why?
|
| Aged | 23 | 2021 | 19978 | 0.210 |
Why?
|
| Adolescent | 19 | 2021 | 19531 | 0.210 |
Why?
|
| Anal Canal | 3 | 2007 | 80 | 0.200 |
Why?
|
| Antiviral Agents | 1 | 2007 | 769 | 0.190 |
Why?
|
| Elephantiasis, Filarial | 1 | 2002 | 13 | 0.190 |
Why?
|
| Humans | 47 | 2024 | 126366 | 0.190 |
Why?
|
| Urogenital Surgical Procedures | 3 | 2008 | 9 | 0.190 |
Why?
|
| Vagina | 4 | 2013 | 185 | 0.190 |
Why?
|
| Child, Preschool | 12 | 2021 | 14207 | 0.180 |
Why?
|
| DNA Fingerprinting | 1 | 2001 | 108 | 0.180 |
Why?
|
| Pregnancy | 10 | 2013 | 7258 | 0.170 |
Why?
|
| Immunogenicity, Vaccine | 1 | 2021 | 108 | 0.170 |
Why?
|
| Child | 17 | 2021 | 24739 | 0.170 |
Why?
|
| Smoke Inhalation Injury | 1 | 2000 | 6 | 0.170 |
Why?
|
| Accident Prevention | 1 | 2000 | 9 | 0.170 |
Why?
|
| Fires | 1 | 2000 | 11 | 0.160 |
Why?
|
| Burns | 1 | 2000 | 79 | 0.160 |
Why?
|
| Hypersensitivity, Delayed | 2 | 1999 | 34 | 0.160 |
Why?
|
| Prevalence | 8 | 2012 | 2484 | 0.160 |
Why?
|
| Double-Blind Method | 2 | 2021 | 1613 | 0.150 |
Why?
|
| Contact Tracing | 1 | 1999 | 54 | 0.150 |
Why?
|
| England | 2 | 2013 | 60 | 0.140 |
Why?
|
| Male | 21 | 2021 | 62042 | 0.140 |
Why?
|
| Disease Susceptibility | 1 | 1998 | 301 | 0.130 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 1999 | 217 | 0.130 |
Why?
|
| Young Adult | 4 | 2021 | 9166 | 0.130 |
Why?
|
| Urinary Bladder | 4 | 2008 | 243 | 0.120 |
Why?
|
| Population Surveillance | 2 | 2012 | 396 | 0.110 |
Why?
|
| Delivery, Obstetric | 2 | 2007 | 251 | 0.110 |
Why?
|
| Drug Therapy, Combination | 3 | 2007 | 1167 | 0.110 |
Why?
|
| Patient Education as Topic | 2 | 2007 | 443 | 0.110 |
Why?
|
| Haemophilus influenzae type b | 1 | 2013 | 5 | 0.110 |
Why?
|
| Haemophilus Vaccines | 1 | 2013 | 30 | 0.110 |
Why?
|
| Infant | 8 | 2013 | 12667 | 0.110 |
Why?
|
| Chlamydia trachomatis | 1 | 2013 | 25 | 0.110 |
Why?
|
| Immunization Schedule | 1 | 2013 | 103 | 0.110 |
Why?
|
| Gonorrhea | 1 | 2013 | 38 | 0.110 |
Why?
|
| Papanicolaou Test | 1 | 2013 | 33 | 0.100 |
Why?
|
| Chlamydia Infections | 1 | 2013 | 49 | 0.100 |
Why?
|
| Vaginal Smears | 1 | 2013 | 48 | 0.100 |
Why?
|
| Haemophilus Infections | 1 | 2013 | 91 | 0.100 |
Why?
|
| Stochastic Processes | 1 | 2013 | 37 | 0.100 |
Why?
|
| History, 19th Century | 1 | 2013 | 118 | 0.100 |
Why?
|
| Anti-Retroviral Agents | 2 | 2012 | 142 | 0.100 |
Why?
|
| Surveys and Questionnaires | 6 | 2007 | 3715 | 0.100 |
Why?
|
| Antigens, Bacterial | 1 | 1994 | 314 | 0.100 |
Why?
|
| Quality of Life | 5 | 2008 | 1955 | 0.100 |
Why?
|
| Combined Modality Therapy | 2 | 2007 | 1253 | 0.100 |
Why?
|
| Suburethral Slings | 2 | 2008 | 7 | 0.090 |
Why?
|
| Health Surveys | 1 | 2012 | 247 | 0.090 |
Why?
|
| Contraceptives, Postcoital | 1 | 2010 | 1 | 0.090 |
Why?
|
| Ovulation Inhibition | 1 | 2010 | 1 | 0.090 |
Why?
|
| Administration, Oral | 2 | 2010 | 703 | 0.090 |
Why?
|
| Contraceptives, Oral, Synthetic | 1 | 2010 | 5 | 0.090 |
Why?
|
| Disease Outbreaks | 1 | 2013 | 321 | 0.090 |
Why?
|
| Levonorgestrel | 1 | 2010 | 21 | 0.090 |
Why?
|
| Unsafe Sex | 1 | 2010 | 22 | 0.090 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2010 | 31 | 0.090 |
Why?
|
| Public Health | 1 | 2013 | 269 | 0.090 |
Why?
|
| Odds Ratio | 3 | 2013 | 1267 | 0.090 |
Why?
|
| Patient Dropouts | 1 | 2010 | 52 | 0.090 |
Why?
|
| Parity | 2 | 2007 | 78 | 0.080 |
Why?
|
| Time Factors | 3 | 2010 | 6338 | 0.080 |
Why?
|
| Menstrual Cycle | 1 | 2010 | 34 | 0.080 |
Why?
|
| Age Distribution | 2 | 2002 | 422 | 0.080 |
Why?
|
| Cross-Sectional Studies | 4 | 2009 | 3456 | 0.080 |
Why?
|
| Dapsone | 1 | 1988 | 6 | 0.080 |
Why?
|
| Surgical Mesh | 2 | 2013 | 61 | 0.080 |
Why?
|
| Urethra | 3 | 2013 | 85 | 0.070 |
Why?
|
| Cohort Studies | 5 | 2010 | 4875 | 0.070 |
Why?
|
| Urologic Surgical Procedures | 1 | 2008 | 57 | 0.070 |
Why?
|
| Trichloroacetic Acid | 1 | 2007 | 4 | 0.070 |
Why?
|
| Cryotherapy | 1 | 2007 | 22 | 0.070 |
Why?
|
| Aminoquinolines | 1 | 2007 | 35 | 0.070 |
Why?
|
| Tinidazole | 1 | 2007 | 1 | 0.070 |
Why?
|
| Rifampin | 1 | 1988 | 131 | 0.070 |
Why?
|
| Antitrichomonal Agents | 1 | 2007 | 10 | 0.070 |
Why?
|
| Age Factors | 4 | 2001 | 2836 | 0.070 |
Why?
|
| Vaginosis, Bacterial | 1 | 2007 | 18 | 0.070 |
Why?
|
| Cicatrix | 1 | 1989 | 125 | 0.070 |
Why?
|
| Rural Population | 2 | 2000 | 259 | 0.070 |
Why?
|
| Physical Examination | 2 | 2004 | 159 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2013 | 2071 | 0.070 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2009 | 233 | 0.070 |
Why?
|
| Postoperative Complications | 4 | 2013 | 3078 | 0.070 |
Why?
|
| Models, Statistical | 2 | 1999 | 479 | 0.070 |
Why?
|
| Endosonography | 1 | 2006 | 80 | 0.060 |
Why?
|
| Lacerations | 1 | 2006 | 33 | 0.060 |
Why?
|
| Cesarean Section | 3 | 2007 | 393 | 0.060 |
Why?
|
| Domestic Violence | 1 | 2005 | 12 | 0.060 |
Why?
|
| Preoperative Care | 1 | 2008 | 359 | 0.060 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 1 | 2024 | 6 | 0.060 |
Why?
|
| Mass Screening | 1 | 2010 | 787 | 0.060 |
Why?
|
| United Kingdom | 2 | 2009 | 202 | 0.060 |
Why?
|
| Spouses | 1 | 2005 | 65 | 0.060 |
Why?
|
| Sex Offenses | 1 | 2005 | 48 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2013 | 1131 | 0.060 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2009 | 458 | 0.060 |
Why?
|
| Abortion, Induced | 1 | 2005 | 77 | 0.060 |
Why?
|
| Depressive Disorder, Major | 1 | 2009 | 411 | 0.060 |
Why?
|
| Truth Disclosure | 1 | 2005 | 102 | 0.060 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2004 | 135 | 0.050 |
Why?
|
| Medical History Taking | 1 | 2004 | 110 | 0.050 |
Why?
|
| Texas | 3 | 2007 | 3586 | 0.050 |
Why?
|
| Research Design | 2 | 2024 | 709 | 0.050 |
Why?
|
| Debridement | 1 | 2003 | 89 | 0.050 |
Why?
|
| Influenza, Human | 1 | 2009 | 666 | 0.050 |
Why?
|
| Methods | 2 | 1996 | 143 | 0.050 |
Why?
|
| Infant, Newborn | 3 | 2001 | 8301 | 0.050 |
Why?
|
| Testicular Hydrocele | 1 | 2002 | 3 | 0.050 |
Why?
|
| Microfilariae | 1 | 2002 | 3 | 0.050 |
Why?
|
| Aged, 80 and over | 5 | 2012 | 6652 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2003 | 3460 | 0.050 |
Why?
|
| Lymphedema | 1 | 2002 | 19 | 0.050 |
Why?
|
| Case-Control Studies | 4 | 2013 | 3343 | 0.050 |
Why?
|
| Hysterectomy, Vaginal | 1 | 2001 | 14 | 0.050 |
Why?
|
| Risk Factors | 5 | 2007 | 10377 | 0.050 |
Why?
|
| Sex Factors | 2 | 2000 | 1293 | 0.050 |
Why?
|
| Netherlands | 1 | 2001 | 38 | 0.040 |
Why?
|
| Incidence | 4 | 2012 | 3166 | 0.040 |
Why?
|
| United States | 2 | 2024 | 10994 | 0.040 |
Why?
|
| Molecular Epidemiology | 1 | 2001 | 156 | 0.040 |
Why?
|
| Epidemiologic Methods | 2 | 1998 | 108 | 0.040 |
Why?
|
| Alabama | 1 | 2000 | 46 | 0.040 |
Why?
|
| Housing | 1 | 2000 | 53 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2001 | 408 | 0.040 |
Why?
|
| Risk | 2 | 2013 | 770 | 0.040 |
Why?
|
| Wales | 1 | 1998 | 5 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2024 | 526 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2003 | 2934 | 0.040 |
Why?
|
| Sex Distribution | 1 | 1999 | 308 | 0.040 |
Why?
|
| Life Style | 1 | 2001 | 423 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2002 | 1204 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2007 | 2901 | 0.030 |
Why?
|
| Health Status Indicators | 2 | 2008 | 123 | 0.030 |
Why?
|
| Urinary Bladder Diseases | 2 | 2006 | 34 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 2000 | 347 | 0.030 |
Why?
|
| Episiotomy | 2 | 2007 | 17 | 0.030 |
Why?
|
| Tinea Versicolor | 1 | 1996 | 1 | 0.030 |
Why?
|
| Interviews as Topic | 2 | 2010 | 380 | 0.030 |
Why?
|
| Models, Biological | 1 | 2001 | 1471 | 0.030 |
Why?
|
| Urodynamics | 2 | 2006 | 40 | 0.030 |
Why?
|
| Colposcopy | 1 | 2014 | 13 | 0.030 |
Why?
|
| Defecation | 1 | 2014 | 30 | 0.030 |
Why?
|
| Patient Compliance | 2 | 2007 | 472 | 0.030 |
Why?
|
| Sacrococcygeal Region | 1 | 2014 | 32 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2008 | 16522 | 0.030 |
Why?
|
| Skin Tests | 1 | 1994 | 77 | 0.030 |
Why?
|
| Patient Satisfaction | 2 | 2008 | 477 | 0.030 |
Why?
|
| Smoking | 1 | 2000 | 1052 | 0.030 |
Why?
|
| Survival Rate | 1 | 1999 | 2071 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 1994 | 207 | 0.030 |
Why?
|
| Neisseria gonorrhoeae | 1 | 2013 | 15 | 0.030 |
Why?
|
| Longitudinal Ligaments | 1 | 2013 | 2 | 0.030 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2013 | 65 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2013 | 84 | 0.030 |
Why?
|
| Culture Media | 1 | 2013 | 182 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2013 | 337 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2003 | 2406 | 0.020 |
Why?
|
| Reoperation | 1 | 2014 | 835 | 0.020 |
Why?
|
| Ultrasonography | 1 | 1996 | 943 | 0.020 |
Why?
|
| Sexual Behavior | 1 | 2012 | 238 | 0.020 |
Why?
|
| Health Status | 1 | 2012 | 385 | 0.020 |
Why?
|
| Health Status Disparities | 1 | 2012 | 230 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 867 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2009 | 257 | 0.020 |
Why?
|
| Urinary Catheterization | 1 | 1988 | 57 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1988 | 258 | 0.020 |
Why?
|
| Urinary Incontinence, Urge | 1 | 2007 | 5 | 0.020 |
Why?
|
| Translations | 1 | 2007 | 16 | 0.020 |
Why?
|
| Urination | 1 | 2007 | 24 | 0.020 |
Why?
|
| Hot Temperature | 1 | 1988 | 140 | 0.020 |
Why?
|
| Mutation | 1 | 2001 | 5961 | 0.020 |
Why?
|
| Flatulence | 1 | 2006 | 4 | 0.020 |
Why?
|
| Perineum | 1 | 2006 | 47 | 0.020 |
Why?
|
| Language | 1 | 2007 | 199 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 731 | 0.020 |
Why?
|
| Logistic Models | 1 | 2010 | 1812 | 0.020 |
Why?
|
| Skin | 1 | 1988 | 527 | 0.010 |
Why?
|
| Pain | 1 | 1988 | 453 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 1692 | 0.010 |
Why?
|
| Psychometrics | 1 | 2007 | 652 | 0.010 |
Why?
|
| Random Allocation | 1 | 2003 | 443 | 0.010 |
Why?
|
| Suture Techniques | 1 | 2003 | 196 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2007 | 1582 | 0.010 |
Why?
|
| Animals | 1 | 2002 | 34548 | 0.010 |
Why?
|
| Medical Records | 1 | 2001 | 192 | 0.010 |
Why?
|
| HIV Infections | 1 | 2012 | 1909 | 0.010 |
Why?
|
| Hospital Costs | 1 | 2001 | 180 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2008 | 6177 | 0.010 |
Why?
|
| Length of Stay | 1 | 2001 | 1325 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 1996 | 316 | 0.010 |
Why?
|